
Triple agonist (GLP-1 + GIP + Glucagon) for maximum weight loss. Significantly reduces appetite and boosts fat burning.
The newest and most powerful weight-loss peptide available — a triple agonist hitting GLP-1, GIP, and glucagon pathways simultaneously. Phase 2 research demonstrated significant metabolic outcomes across study participants.